deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT03178695

Inovium Ovarian Rejuvenation Trials

Autologous Platelet-Rich Plasma (PRP) Infusions and Biomarkers of Ovarian Rejuvenation and Aging Mitigation

Sponsor: Ascendance Biomedical

Conditions Infertility Infertility Unexplained Infertility, Female Menopause Menopause Premature Asymptomatic Menopause Premature Symptomatic Menopause Related Conditions Menopause, Premature Perimenopausal Disorder Premature Ovarian Failure Premature Ovarian Failure 1 Premature Ovarian Failure 2A Premature Ovarian Failure 3 Premature Ovarian Failure 4 Premature Ovarian Failure 5 Premature Ovarian Failure 6 Premature Ovarian Failure 7 Premature Ovarian Failure 8 Premature Ovarian Failure 9 Premature Ovarian Failure, Familial
Interventions Autologous PRP injection into human ovarian tissue
Updated 9 times since 2017 Last updated: Apr 16, 2020 Started: Jun 1, 2017 Primary completion: May 1, 2018 Completion: May 1, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Infertility and Infertility Unexplained and is currently completed. Ascendance Biomedical leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshotNot Yet Recruiting~Aug 2017 – ~Oct 2017 · 2 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshotCompleted~Feb 2020 – ~May 2020 · 3 months · monthly snapshotCompleted~May 2020 – ~Jan 2021 · 8 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. May 2020 — Jan 2021 [monthly]

    Completed PHASE1

  5. Feb 2020 — May 2020 [monthly]

    Completed PHASE1

▶ Show 4 earlier versions

  1. Jun 2018 — Feb 2020 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  2. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  3. Aug 2017 — Oct 2017 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  4. Jun 2017 — Aug 2017 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ascendance Biomedical
Data source: Ascendance Biomedical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations